摘要
目的对应用拉米夫定+阿德福韦酯对患有慢性乙型肝炎的患者实施治疗的临床效果进行研究。方法抽取90例患有慢性乙型肝炎的患者,随机分为对照组和治疗组,平均每组45例。采用拉米夫定对对照组患者实施治疗;采用拉米夫定与阿德福韦酯联合对治疗组患者实施治疗。结果治疗组患者慢性乙型肝炎症状治疗效果明显优于对照组;治疗前后肝功能指标改善幅度明显大于对照组;乙肝控制时间和实际用药治疗时间明显短于对照组。结论应用拉米夫定+阿德福韦酯对患有慢性乙型肝炎的患者实施治疗的临床效果非常明显。
Objective To study the application of lamivudine ＋ adefovir dipivoxil implementation of the clinical effect of treatment of patients with chronic hepatitis B. Methods A total of 90 patients suffering from chronic hepatitis B patients, randomly divided into control group and treatment group, 45 cases in each group, the average. Use of lamivudine on the treatment group patients; lamivudine and adefovir dipivoxil combined with the treatment group patients were treated. Results The curative effect of chronic hepatitis B patients with symptoms of treatment group was significantly better than the control group; before and after treatment liver function index improved significantly more than the control group; hepatitis B control time and the actual treatment time was shorter than the control group. Conclusion Lamivudine ＋ adefovir dipivoxil on patients with chronic hepatitis B in the implementation of the clinical treatment effect is very obvious.
出处
《中国医药指南》
2013年第21期50-51,共2页
Guide of China Medicine
